Nav: Home

Discovery could lead to treatment to better regulate insulin

July 12, 2016

AMES, Iowa - Medication can help trigger the enzyme that kick starts insulin production in the body, but the drugs don't always work for those who are obese or diabetic, and most need to regulate their glucose and insulin levels. That's why a recent discovery made by Rudy Valentine and a team of researchers holds so much promise.

The team has spent years studying the enzyme AMP-activated protein kinase or AMPK - a main energy sensor in the body. Valentine, an assistant professor of kinesiology at Iowa State University, says AMPK is reduced in obese and diabetics, putting them at risk for metabolic complications, such as stroke, heart disease and some forms of cancer.

Researchers know a lot about how to activate this enzyme, but are working to understand why AMPK is being reduced, he said. By examining the molecular and cellular process, Valentine and his colleagues at Boston University School of Medicine and Harvard Medical School came up with another piece of the puzzle. They found the protein PKD1 may limit AMPK's activity, which leads to impaired insulin signaling in the muscle, a hallmark of diabetes, Valentine said. The results were published earlier this year in The Journal of Biological Chemistry.

"It's a pretty technical process," he said. "There are probably a lot of different molecules that are also involved in this process, but this is definitely one of the mechanisms by which the molecule AMPK is downregulated."

One way to help understand the process is to think of AMPK as a commuter train or bus you take to and from work. PKD1 is like a construction project blocking the exits from the road or tracks and backing up traffic. In your body, PKD1 slows the cells that remove glucose from the bloodstream causing a "back up" or increase of blood glucose, which has significant consequences. Valentine says it's also similar to trying to accelerate with your foot on the brake and PKD1 is the brake.

Once researchers identified PKD1 as a potential problem, they took two different approaches - one using medication and the other involved gene silencing to inhibit PKD1 - to determine if it's possible to restrain or prevent the enzyme from limiting AMPK. Valentine says they're encouraged by the fact that lowering PKD1 by both approaches effectively restored AMPK activity and insulin signaling. The next step is to determine if existing drugs or modifying certain drugs may be an effective treatment option.

Exercise may also have potential

As an exercise physiologist, Valentine is interested in the impact of physical activity and nutrition in this process. Researchers know that when AMPK is activated it helps the body realize the metabolic benefits of exercise, which can improve insulin sensitivity. Valentine says diet may also play a role.

"We want to know if there are lifestyle things people can do such as nutraceuticals and certain foods that can inhibit this enzyme and lead to more activation of AMPK and improve insulin sensitivity," Valentine said.

Exercise may not be a practical solution for people with physical impairments or other health issues. However, Valentine says the work may help identify areas they can target with other types of therapy.
-end-
Lead author Kimberly A. Coughlan, along with Bella S. Sudit, Katherine Allen, Neil B. Ruderman and Asish K. Saha, all at Boston University School of Medicine; as well as Yossi Dagon and Barbara B. Kahn, both at Harvard Medical School, contributed to this research. The study was supported by grants from U.S. Public Health Services, National Institutes of Health and the JPB Foundation.

Iowa State University

Related Glucose Articles:

Injectable solution may provide weeks of glucose control
Biomedical engineers at Duke University have created a biopolymer that can provide weeks of glucose control with a single injection.
Sugar sponges sop up and release glucose as needed
Many diabetes patients must inject themselves with insulin, sometimes several times a day, while others take medications orally to control blood sugar.
Not such a 'simple' sugar -- glucose may help fight cancer and inflammatory disease
Scientists have just discovered that glucose, the most important fuel used in our bodies, also plays a vital role in the immune response.
Convenient and easy to use glucose monitoring and maintenance
A research group from the Center for Nanoparticle Research within the Institute for Basic Science has developed a convenient and accurate sweat-based glucose monitoring and maintenance device.
How rare sugars might help control blood glucose
In an era when the label 'natural' hits a sweet spot with consumers, some uncommon sugars emerging on the market could live up to the connotation.
Neuronal stimulation regulates appetite and glucose levels in mice
This week in the JCI, a study led by Michael Scott at the University of Virginia explores how stimulation of a subset of neurons that produce glucagon-like peptides can control appetite and glucose levels in lean and obese mice.
Renoprotective effects of sglt2 inhibitors: Beyond glucose reabsorption inhibition
In this manuscript we summarize the available data on the mechanisms that underlie the renoprotective properties of SGLT2 inhibitors.
Mouse models indicate burning more fat and less glucose could lead to diabetes
Making muscles burn more fat and less glucose can increase exercise endurance, but could simultaneously cause diabetes, says a team of scientists from Baylor College of Medicine and other institutions.
Immune system uses gut bacteria to control glucose metabolism
Researchers have discovered an important link between the immune system, gut bacteria and glucose metabolism -- a 'cross-talk' and interaction that can lead to type 2 diabetes and metabolic syndrome when not functioning correctly.
Researchers discover new regulator in glucose metabolism
A key genetic switch in the liver regulates glucose metabolism and insulin action in other organs of the body.

Related Glucose Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Anthropomorphic
Do animals grieve? Do they have language or consciousness? For a long time, scientists resisted the urge to look for human qualities in animals. This hour, TED speakers explore how that is changing. Guests include biological anthropologist Barbara King, dolphin researcher Denise Herzing, primatologist Frans de Waal, and ecologist Carl Safina.
Now Playing: Science for the People

#SB2 2019 Science Birthday Minisode: Mary Golda Ross
Our second annual Science Birthday is here, and this year we celebrate the wonderful Mary Golda Ross, born 9 August 1908. She died in 2008 at age 99, but left a lasting mark on the science of rocketry and space exploration as an early woman in engineering, and one of the first Native Americans in engineering. Join Rachelle and Bethany for this very special birthday minisode celebrating Mary and her achievements. Thanks to our Patreons who make this show possible! Read more about Mary G. Ross: Interview with Mary Ross on Lash Publications International, by Laurel Sheppard Meet Mary Golda...